268 related articles for article (PubMed ID: 32661765)
1. Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications.
Nadpara N; Reichenbach ZW; Ehrlich AC; Friedenberg F
Dig Dis Sci; 2020 Oct; 65(10):2769-2779. PubMed ID: 32661765
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
Bates J; Diehl L
J Pathol; 2014 Jan; 232(2):112-20. PubMed ID: 24122796
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Bowel Disease - Non-biological treatment.
Magro F; Cordeiro G; Dias AM; Estevinho MM
Pharmacol Res; 2020 Oct; 160():105075. PubMed ID: 32653651
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate for inflammatory bowel disease: time for reconsideration.
Nielsen OH; Ainsworth MA; Steenholdt C
Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):407-409. PubMed ID: 30895827
[No Abstract] [Full Text] [Related]
5. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Hanauer SB; Sandborn WJ; Lichtenstein GR
Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
Liu Y; Wang X; Hu CA
Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.
Billmeier U; Dieterich W; Neurath MF; Atreya R
World J Gastroenterol; 2016 Nov; 22(42):9300-9313. PubMed ID: 27895418
[TBL] [Abstract][Full Text] [Related]
8. Controlling leukocyte trafficking in IBD.
Veny M; Fernández-Clotet A; Panés J
Pharmacol Res; 2020 Sep; 159():105050. PubMed ID: 32598943
[TBL] [Abstract][Full Text] [Related]
9. What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?
Lawrance IC
World J Gastroenterol; 2014 Feb; 20(5):1248-58. PubMed ID: 24574799
[TBL] [Abstract][Full Text] [Related]
10. Histological healing in inflammatory bowel disease: a still unfulfilled promise.
Villanacci V; Antonelli E; Geboes K; Casella G; Bassotti G
World J Gastroenterol; 2013 Feb; 19(7):968-78. PubMed ID: 23467585
[TBL] [Abstract][Full Text] [Related]
11. [Inflammatory diseases of the intestines].
Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
[TBL] [Abstract][Full Text] [Related]
12. [Conservative therapy of inflammatory bowel diseases].
Nagy F
Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315
[TBL] [Abstract][Full Text] [Related]
13. Personalizing therapy for inflammatory bowel diseases.
Ananthakrishnan AN
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):549-58. PubMed ID: 23985004
[TBL] [Abstract][Full Text] [Related]
14. Vedolizumab for the treatment of ulcerative colitis.
Shahidi N; Bressler B; Panaccione R
Expert Opin Biol Ther; 2016; 16(1):129-35. PubMed ID: 26567768
[TBL] [Abstract][Full Text] [Related]
15. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Ledder O; Lemberg DA; Day AS
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory pathways of importance for management of inflammatory bowel disease.
Pedersen J; Coskun M; Soendergaard C; Salem M; Nielsen OH
World J Gastroenterol; 2014 Jan; 20(1):64-77. PubMed ID: 24415859
[TBL] [Abstract][Full Text] [Related]
18. Therapy of inflammatory bowel disease: what to expect in the next decade.
Leiman DA; Lichtenstein GR
Curr Opin Gastroenterol; 2014 Jul; 30(4):385-90. PubMed ID: 24902037
[TBL] [Abstract][Full Text] [Related]
19. The role of integrin antagonists in the treatment of inflammatory bowel disease.
Beniwal-Patel P; Saha S
Expert Opin Biol Ther; 2014 Dec; 14(12):1815-23. PubMed ID: 25288228
[TBL] [Abstract][Full Text] [Related]
20. Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.
Quetglas EG; Armuzzi A; Wigge S; Fiorino G; Barnscheid L; Froelich M; Danese S
Eur J Clin Pharmacol; 2015 Jul; 71(7):773-99. PubMed ID: 26008212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
